En Es
Categories

HOLOGIC Diagnostics

HOLOGIC Diagnostics

HOLOGIC Diagnostics offers innovative technology for cytology, molecular and perinatal testing that helps deliver answers and guide patient care. The company’s diagnostic solutions offer early, accurate detection of HPV, chlamydia, gonorrhea, HIV and other diseases, often within days of infection.
Products Summary
Close

About HOLOGIC Diagnostics

HOLOGIC Diagnostics offers innovative technology for cytology, molecular and perinatal testing that helps deliver answers and guide patient care. The company’s diagnostic solutions offer early, accurate detection of HPV, chlamydia, gonorrhea, HIV and other diseases, often within days of infection.

Recently updated

Trichomonas Vaginalis Diagnostic Test
Aptima Trichomonas Vaginalis Assay

The Aptima Trichomonas vaginalis assay is an rRNA-based NAAT that provides up to 100% sensitivity in detecting TV for both symptomatic and asymptomatic patients. The assay overcomes challenges associated with traditional, less sensitive methodologies by detecting a fraction of one organism, whereas wet mount requires at least 10,000 motile organisms/mL to visualize.
More details

Molecular HBV Treatment Management Assay
Aptima HBV Quant Assay

The Aptima HBV Quant Assay is a molecular HBV treatment management assay with a dual-target design. It helps providers guide treatment management for patients with chronic hepatitis B infection who are undergoing antiviral therapy.
More details

HIV-1 Infection Test
Aptima HIV-1 Quant Dx Assay

The Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management. It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving labs excellent precision and sensitivity for HIV-1 detection and viral load monitoring.
More details

Clinical Laboratory

Trichomonas Vaginalis Diagnostic Test
Aptima Trichomonas Vaginalis Assay

The Aptima Trichomonas vaginalis assay is an rRNA-based NAAT that provides up to 100% sensitivity in detecting TV for both symptomatic and asymptomatic patients. The assay overcomes challenges associated with traditional, less sensitive methodologies by detecting a fraction of one organism, whereas wet mount requires at least 10,000 motile organisms/mL to visualize.
More details

Molecular HBV Treatment Management Assay
Aptima HBV Quant Assay

The Aptima HBV Quant Assay is a molecular HBV treatment management assay with a dual-target design. It helps providers guide treatment management for patients with chronic hepatitis B infection who are undergoing antiviral therapy.
More details

HIV-1 Infection Test
Aptima HIV-1 Quant Dx Assay

The Aptima HIV-1 Quant Dx assay is a dual-claim assay that can be used to confirm HIV-1 infection and measure viral load for optimal patient management. It offers reliable quantitation of HIV-1 RNA across a broad linear range, giving labs excellent precision and sensitivity for HIV-1 detection and viral load monitoring.
More details

Mycoplasma Genitalium Assay
Aptima Mycoplasma Genitalium Assay

The Aptima Mycoplasma genitalium Assay is an in vitro nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium on the fully automated Panther system. It is intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients.
More details

Herpes Simplex Assay
Aptima HSV 1 & 2 Assay

The Aptima HSV 1 & 2 assay for HSV diagnosis distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals when compared to culture and other instrument platforms. It is suitable for diagnosis of genital herpes due to higher sensitivity, ease of specimen collection and transportation and faster results.
More details

Herpes Simplex NAAT Test
Aptima Herpes Simplex Viruses 1 & 2 Assay

The Aptima Herpes Simplex Viruses 1 & 2 assay is an in vitro diagnostic nucleic acid amplification test (NAAT), using real time transcription-mediated amplification (TMA), for the qualitative detection and differentiation of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) messenger RNA (mRNA) in clinician-collected swab specimens from anogenital skin lesions. It distinguishes between HSV-1 and HSV-2 with significant reduction in hands-on time for laboratory professionals when compared to culture and other instrument platforms.
More details

Chlamydia Trachomatis/Neisseria Gonorrhoeae Assay
APTIMA Combo 2 Assay

The APTIMA Combo 2 Assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal RNA (rRNA) from Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) in endocervical and male urethral swab specimens, and in female and male urine specimens. The assay may be used to test specimens from symptomatic and asymptomatic individuals to aid in the diagnosis of gonococcal and/or chlamydial urogenital disease using the TIGRIS DTS automated analyzer or semi-automated instrumentation as specified.
More details

Quantitative HCV RNA Test
Aptima HCV Quant Dx Assay

The Aptima HCV Quant Dx Assay detects and quantitates HCV RNA and is intended for use as an aid in the diagnosis of active HCV infection following a positive HCV antibody test and in the clinical management of patients infected with HCV. It detects and quantitates HCV RNA genotypes 1, 2, 3, 4, 5, and 6 and provides industry-leading sensitivity in even the lowest-level HCV concentrations.
More details

Molecular Diagnostic System
Panther Trax

Panther Trax represents the latest addition to the Panther Scalable Solutions (PSS) portfolio of products, offering the ultimate in lab automation by physically linking multiple Panther instruments together into a single, powerful workcell that allows labs to increase testing volumes without increasing staff. With Panther Trax, labs can customize configuration to meet space constraints and minimize facility costs.
More details

Digital Cytology Platform
Genius Digital Diagnostics

Genius Digital Diagnostics is the first CE-marked digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced volumetric imaging technology to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women. The system can rapidly analyze all cells on a ThinPrep® Pap test digital image, narrowing tens of thousands of cells down to an AI-generated gallery of the most diagnostically relevant images. This will help provide healthcare providers with the critical information they need to guide earlier detection and better treatment decisions for the patients they serve.
More details

Automated Molecular Diagnostic Analyzer
Novodiag

The Novodiag system is a fully automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance that combines real-time PCR and microarray capabilities. This enables multiple pathogens to be identified in a single sample, providing a simple and fast way to pinpoint patients most at risk with targeted and syndromic on-demand testing. Its CE-IVD test menu includes highly multiplexed on-demand assays detecting gastrointestinal infections and antibiotic resistance, as well as a targeted assay for the detection of SARS-CoV-2.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions